{"id":25997,"date":"2024-08-20T08:40:25","date_gmt":"2024-08-20T08:40:25","guid":{"rendered":"https:\/\/rhepa.se\/?p=25997"},"modified":"2024-08-20T09:08:25","modified_gmt":"2024-08-20T09:08:25","slug":"rhenman-partners-strengthens-investment-team-hires-additional-biopharma-pm","status":"publish","type":"post","link":"https:\/\/rhepa.se\/en\/rhenman-partners-strengthens-investment-team-hires-additional-biopharma-pm\/","title":{"rendered":"Rhenman & Partners strengthens investment team \u2013 hires additional biopharma PM"},"content":{"rendered":"
Rhenman & Partners hires Camilla Oxhamre Cruse as Portfolio Manager \u2013 biotech and pharma. She will have a particular focus on companies within pharmaceutical development. Camilla joins Rhenman & Partners’ investment team of four people, all based in their Stockholm office. Camilla has a master’s degree in biochemistry from Lund University (Lund) and obtained a doctorate in medicine from Karolinska Institutet (Stockholm). In addition, she has an MBA from Hawaii Pacific University in the US and has studied at the \u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier in France. Camilla has spent most of her career in the financial industry in a variety of advisory and analyst roles with a focus on the healthcare sector. This includes roles at Newton Investment Management (London), William Blair Investment Management (Chicago and London) and Carnegie Investment Bank (Stockholm). Camilla is ESG certified via PRI Academy.<\/p>\n
“We are very pleased that Camilla will become part of Rhenman & Partners. Camilla’s long international background and broad expertise in the medical field and her experience in the financial markets will be a strong addition to our organization. Camilla will work closely with the entire investment team, focusing on the biotech and pharmaceutical sub-sectors where we continue to see great potential.\u201d – says Henrik Rhenman, co-founder and CIO at Rhenman & Partners.<\/p>\n
“I look forward to joining Rhenman & Partners. It is a company that I have followed for a long time and that has impressed me with its in-depth fundamental analysis in the healthcare sector, integrity and skillful management which has led to a long track record of positive returns. I am really pleased to become part of the team and to be able to contribute with my many years of analytical experience of the global pharmaceutical sector.\u201d – says Camilla Oxhamre Cruse.<\/p>\n
Camilla joins Rhenman & Partners at the beginning of September.<\/p>\n\n
Camilla Oxhamre Cruse<\/p>\n
Click here for a PDF version of the news article.<\/a><\/p>\n
\n